Information
-
Patent Application
-
20230295222
-
Publication Number
20230295222
-
Date Filed
March 10, 2023a year ago
-
Date Published
September 21, 2023a year ago
-
Inventors
-
Original Assignees
-
CPC
-
-
International Classifications
- C07K1/13
- G01N33/58
- G01N33/68
- C07K1/107
- C07D235/02
- C07C49/603
Abstract
The present invention relates to methods to use cyclohexan-1,2-dione (CHD) groups to attach labels, linkers, and other molecules to a target compound comprising a CHD-reactive group such as a guanidine, amidine, urea, thiourea and the like. Methods of the invention include milder conditions than those previously known for promoting reaction of CHD with CHD-reactive groups, which makes the methods suitable for use with base-sensitive compounds and complex biomolecules. Methods of the invention are especially useful for attaching linking and labeling groups to a peptide that comprises at least one arginine residue, and can also be used to link such peptides to other target molecules such as nucleic acids. The invention also provides CHD-containing conjugation reagents and compositions comprising CHD-containing intermediates, and precursors useful for making CHD-containing compounds that can be used in the methods of the invention.
Claims
- 1-32. (canceled)
- 33. A composition comprising a peptide-polynucleotide conjugate, wherein a covalent linkage connecting a peptide and a polynucleotide of the peptide-polynucleotide conjugate comprises the following substructure (D):
or a tautomer thereof, wherein:
the dashed bond to Nuc represents where substructure (D) is linked to the polynucleotide;the dashed bond to Pep represents where substructure (D) is linked to the peptide;R4 is an optional substituent on the cyclopentyl ring, andeach R4 is independently selected from the group consisting of C1-2 alkyl, C1-2 alkoxy, C1-2 haloalkyl, -COOR, SO3R, halo, hydroxy, and C(O)NR2;each R is independently H or C1-4 alkyl optionally substituted with up to three groups selected from the group consisting of halo, OH, C1-2 alkyl, C1-2 haloalkyl, C1-2 alkoxy, and carbonyl (oxo), or two R groups on one N are forming a 4-8 membered ring optionally containing an additional one or two heteroatoms selected from N, O and S as ring members and optionally substituted with one or two groups selected from halo, C1-2 alkyl, C1-2 haloalkyl, C1-2 alkoxy, hydroxy, and carbonyl (oxo); and n is 0, 1, 2 or 3.
- 34. The composition of claim 33, further comprising a solid support, wherein the peptide is attached to the solid support via a linker.
- 35. (canceled)
- 36. The composition of claim 33, wherein the covalent linkage is attached to an arginine residue of the peptide.
- 37. (canceled)
- 38. The composition of claim 34, wherein the peptide is covalently attached to the solid support and the linker is a cleavable linker.
- 39. (canceled)
- 40. The composition of claim 33, wherein the covalent linkage comprises substructure (D′):
.
- 41-53. (canceled)
- 54. The composition of claim 34, wherein an N-terminal amino acid (NTAA) of the peptide forms a covalent bond with the linker.
- 55. The composition of claim 54, wherein the covalent bond between the NTAA and the linker is an amide bond.
- 56. The composition of claim 33, wherein the polynucleotide comprises a barcode.
- 57. The composition of claim 40, wherein the covalent linkage is attached to an arginine residue of the peptide.
Provisional Applications (1)
|
Number |
Date |
Country |
|
63108282 |
Oct 2020 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
17535516 |
Nov 2021 |
US |
Child |
18182199 |
|
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/US2021/057144 |
Oct 2021 |
WO |
Child |
17535516 |
|
US |